Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rank in Stocks #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Share Price
$2.20
Last synced: 2026-09-01
Market Cap
$253.81M
Change (1 day)
10.29%
Change (1 year)
99.67%
Country
CA
Trade Cardiol Therapeutics Inc. (CRDL)

Category

Stock split history for Cardiol Therapeutics Inc. (CRDL)
Cardiol Therapeutics Inc. stock (symbol: CRDL) underwent a total of 0 stock splits.
The most recent stock split occurred on Sep 02, 2026.
One CRDL share bought prior to Sep 02, 2026 would equal to 0 CRDL shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors